San Diego, CA.  DTx Pharma, an RNA medicines company breaking open new therapeutic areas for oligonucleotide therapeutics, today announced that it will attend the 2019 Biotech Showcase at the JP Morgan Healthcare Conference in San Francisco, CA from January 7-9, 2019.

DTx Pharma will present on January 9th, 2019 at 11:45AM PST in the Franciscan C Ballroom at the Hilton San Francisco Union Square. 

DTx Pharma was also selected as one of eight participants in the west coast innovators pitch challenge.  DTx will present to a panel of early stage investors on Tuesday, January 8th, 2019 between 1 and 3PM PST at the Marines’ Memorial Club & Hotel. 

“The single biggest obstacle limiting the expansion of oligonucleotide therapeutics as a class is delivery,” said Arthur Suckow, Ph.D, CEO DTx Pharma.  “Our technology leverages fatty acids as targeting ligands to enable development of RNA medicines for novel therapeutic areas. We look forward to meeting with investors and potential partners as we seek to move candidates into early clinical development.”

Contact Us Here